266
Views
6
CrossRef citations to date
0
Altmetric
Review Articles

Proposition of standardized protocol for photodynamic therapy for vulvar lichen sclerosus

, &
Pages 560-568 | Received 28 Apr 2020, Accepted 14 May 2020, Published online: 01 Jun 2020

References

  • Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc. 1971;57( 1):9–30.
  • Leibovitz A, Kaplun V, Saposhnicov N, et al. Vulvovaginal examinations in elderly nursing home women residents. Arch Gerontol Geriatr. 2000;31( 1):1–4.
  • Bleeker MCG, Visser PJ, Overbeek LIH, et al. Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2016;25( 8):1224–1230.
  • Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151( 10):1061–1067.
  • Powell J, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353( 9166):1777–1783.
  • Pérez-López FR, Ceausu I, Depypere H, et al. EMAS clinical guide: vulvar lichen sclerosus in peri and postmenopausal women. Maturitas. 2013;74( 3):279–282.
  • Lee A, Fischer G. Diagnosis and treatment of vulvar lichen sclerosus: an update for dermatologists. Am J Clin Dermatol. 2018;19( 5):695–706.
  • van de Nieuwenhof HP, Meeuwis KAP, Nieboer TE, et al. The effect of vulvar lichen sclerosus on quality of life and sexual functioning. J Psychosom Obstet Gynecol. 2010;31( 4):279–284.
  • Kirtschig G, Becker K, Günthert A, et al. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol. 2015;29( 10):e1–e43.
  • van de Nieuwenhof HP, van der Avoort IAM, de Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol. 2008;68( 2):131–156.
  • Carli P, Cattaneo A, De Magnis A, et al. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev. 1995;4(6):491–495.
  • Goldstein AT, Marinoff SC, Christopher K, et al. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med. 2005;50:477–480.
  • Seer.cancer.gov [Internet]. Cancer stat fact sheets: vulvar cancer. Belgium: NIH; 2018. [cited 2019 Nov 27]. Available from: https://seer.cancer.gov/statfacts/html/vulva.html
  • Chi CC, Kirtschig G, Baldo M, et al. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev. 2011;2011:CD008240.
  • Neill SM, Tatnall FM, Cox NH. BAD guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2002;147(4):640–649.
  • Belotto RA, Chavantes MC, Tardivo JP, et al. Therapeutic comparison between treatments for Vulvar Lichen Sclerosus: study protocol of a randomized prospective and controlled trial. BMC Womens Health. 2017;17:1–8.
  • Biniszkiewicz T, Olejek A, Kozak-Darmas I, et al. Therapeutic effects of 5-ALA-induced photodynamic therapy in vulvar lichen sclerosus. Photodiagnosis Photodyn Ther. 2005;2( 2):157–160.
  • Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, et al. Vulvar lichen sclerosus.Arch Dermatol. 2004;140( 6):709–712.
  • Yesudian PD. The role of calcineurin inhibitors in the management of lichen sclerosus. Am J Clin Dermatol. 2009;10( 5):313–318.
  • Committee on Safety of Medicines and the Medicines and Healthcare products Regulatory Agency. Salmeterol (Serevent) and formoterol (Oxis, Foradil) in asthma management. Curr Probl Pharmacovigil. 2006;31:6.
  • Smith YR, Haefner HK. Vulvar Lichen sclerosus : pathophysiology and treatment. Am J Clin Dermatol. 2004;5( 2):105–125.
  • Morton CA, Szeimies RM, Sidoroff A, et al. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - Actinic keratoses, Bowen’s disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013;27( 5):536–544.
  • Morton C, Szeimies RM, Sidoroff A, et al. European dermatology forum guidelines on topical photodynamic therapy. Eur J Dermatol. 2015;25( 4):296–311.
  • Grandi V, Sessa M, Pisano L, et al. Photodynamic therapy with topical photosensitizers in mucosal and semimucosal areas: review from a dermatologic perspective. Photodiagnosis Photodyn Ther. 2018;23:119–131.
  • Babilas P, Schreml S, Landthaler M, et al. Photodynamic therapy in dermatology: state-of-the-art. Photodermatol Photoimmunol Photomed. 2010;26( 3):118–132.
  • Fistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol. 2013;14( 1):27–47.
  • Lan T, Zou Y, Hamblin MR, et al. 5-Aminolevulinic acid photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus: series of ten cases. Photodiagnosis Photodyn Ther. 2018;21:234–238.
  • Hillemanns P, Untch M, Pröve F, et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol. 1999;93( 1):71–74.
  • Osiecka BJ, Nockowski P, Jurczyszyn K, et al. Photodynamic therapy of vulvar lichen sclerosus et atrophicus in a woman with hypothyreosis-case report. Photodiagnosis Photodyn Ther. 2012;9( 2):186–188.
  • Sotiriou E, Panagiotidou D, Ioannidis D. An open trial of 5-aminolevulinic acid photodynamic therapy for vulvar lichen sclerosus. Eur J Obstet Gynecol Reprod Biol. 2008;141( 2):187–188.
  • Sotiriou E, Apalla Z, Patsatsi A, et al. Recalcitrant vulvar lichen sclerosis treated with aminolevulinic acid-photodynamic therapy: a report of five cases. J Eur Acad Dermatol Venereol. 2008;22( 11):1398–1399.
  • Romero A, Hernández-Núñez A, Córdoba-Guijarro S, et al. Treatment of recalcitrant erosive vulvar lichen sclerosus with photodynamic therapy. J Am Acad Dermatol. 2007;57( 2):S46–S47.
  • Osiecka BJ, Jurczyszyn K, Nockowski P, et al. Photodynamic therapy with green light for the treatment of vulvar lichen sclerosus – preliminary results. Photodiagnosis Photodyn Ther. 2017;17:185–187.
  • Shi L, Miao F, Zhang L, et al. Comparison of 5-aminolevulinic acid photodynamic therapy and clobetasol propionate in treatment of vulvar lichen sclerosus. Acta Derm Venerol. 2016;96( 5):684–688.
  • Olejek A, Gabriel I, Bilska-Janosik A, et al. ALA-Photodynamic treatment in lichen sclerosus-clinical and immunological outcome focusing on the assesment of antinuclear antibodies. Photodiagnosis Photodyn Ther. 2017;18:128–132.
  • Maździarz A, Osuch B, Kowalska M, et al. Photodynamic therapy in the treatment of vulvar lichen sclerosus. Photodiagnosis Photodyn Ther. 2017;19:135–139.
  • Olejek A, Steplewska K, Gabriel A, et al. Efficacy of photodynamic therapy in vulvar lichen sclerosus treatment based on immunohistochemical analysis of CD34, CD44, myelin basic protein, and Ki67 antibodies. Int J Gynecol Cancer. 2010;20( 5):879–887.
  • Zawislak AA, McCluggage WG, Donnelly RF, et al. Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system. Photodermatol Photoimmunol Photomed. 2009;25( 2):111–113.
  • Vano-Galvan S, Fernandez-Guarino M, Beà-Ardebol S, et al. Successful treatment of erosive vulvar lichen sclerosus with methylaminolaevulinic acid and laser-mediated photodynamic therapy. J Eur Acad Dermatol Venereol. 2009;23( 1):71–72.
  • Imbernón-Moya A, Martínez-Pérez M, Churruca-Grijelmo M, et al. Photodynamic therapy as a therapeutic alternative in vulvar lichen sclerosus: series of 8 cases. Photodermatol Photoimmunol Photomed. 2016;32( 5–6):307–310.
  • Cabete JMF, Campos S, Lestre S. Conscious sedation with inhaled 50% nitrous oxide/oxygen premix in photodynamic therapy sessions for vulvar lichen sclerosus treatment. An Bras Dermatol. 2015;90( 1):120–122.
  • Li J, Zhang GQ. Light-emitting diodes: materials, processes, devices and applications. Cham, Switzerland: Springer; 2019.
  • Capriotti K, Capriotti JA. Dimethyl sulfoxide: history, chemistry, and clinical utility in dermatology. J Clin Aesthet Dermatol. 2012;5( 9):24–26.
  • De Rosa FS, Marchetti JM, Thomazini JA, et al. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J Control Release. 2000;65( 3):359–366.
  • O’Mathuna DP. Topical DMSO for pain. Altern Med Alert. 2006;9(1):1–4.
  • Warren CB, Karai LJ, Vidimos A, et al. Pain associated with aminolevulinic acid-photodynamic therapy of skin disease. J Am Acad Dermatol. 2009;61( 6):1033–1043.
  • ISRCTN registry [Internet]. Belgium: BMC; 2019. [cited 2019 Aug 24]. Availible from: http://www.isrctn.com/
  • Find a study. National library of medicine. ClinicalTrials.gov [Internet]. Belgium: NIH U.S. 2018. [cited 2019 Aug 24]. Available from: https://www.clinicaltrials.gov/
  • International clinical trials registry platform search portal [Internet]. Belgium: World Health Organization; 2018.[cited 2019 Aug 24]. Available from: http://apps.who.int/trialsearch/default.aspx
  • Cochrane library [Internet]. Belgium: John Wiley & Sons, Inc; c2000 – 2020. [cited 2019 Aug 21]. Available from: https://www.cochranelibrary.com/central
  • Clinical trials. EU clinical trials register [Internet]. Belgium: European Medicines Agency; c1995–2020. [cited 2019 Aug 24]. Available from: https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015640-42/BE
  • PubMed.gov [Internet]. Belgium: National Center for Biotechnology Information, U.S. National Library of Medicine; [cited 2019 Aug 21]. Available from: https://www-ncbi-nlm-nih-gov.kuleuven.ezproxy.kuleuven.be/pubmed?myncbishare=kuleuven
  • Embase quick search. Embase [Internet]. Belgium: ELSEVIER; 2019. [cited 2019 Aug 21]. Available from: https://www-embase-com.kuleuven.ezproxy.kuleuven.be/#search

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.